Kuhnil Biopharm

Kuhnil Pharmaceutical is a prominent South Korean pharmaceutical company established in 1957, specializing in the development and commercialization of innovative medicines and high-quality generics. The company is widely recognized for its leadership in the cardiovascular and central nervous system (CNS) therapeutic areas, notably for its successful omega-3 based products like Omacor. Through its specialized subsidiary Penmix, Kuhnil provides extensive contract development and manufacturing (CDMO) services, particularly for sterile injectables. The company's R&D strategy focuses on creating value-added medicines, including fixed-dose combinations and improved formulations for chronic disease management. Kuhnil maintains a strong domestic presence while expanding its global footprint through strategic partnerships and international licensing agreements.